ASEP Medical Holdings (ASEP Medical Holdings) Retained Earnings : $-11.63 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. ASEP Medical Holdings's retained earnings for the quarter that ended in Mar. 2024 was $-11.63 Mil.

ASEP Medical Holdings's quarterly retained earnings declined from Sep. 2023 ($-9.56 Mil) to Dec. 2023 ($-11.17 Mil) and declined from Dec. 2023 ($-11.17 Mil) to Mar. 2024 ($-11.63 Mil).

ASEP Medical Holdings's annual retained earnings declined from Dec. 2021 ($-1.72 Mil) to Dec. 2022 ($-4.95 Mil) and declined from Dec. 2022 ($-4.95 Mil) to Dec. 2023 ($-11.17 Mil).

ASEP Medical Holdings Retained Earnings Historical Data

The historical data trend for ASEP Medical Holdings's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings Retained Earnings Chart

ASEP Medical Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

-1.72

-4.95

-11.17

ASEP Medical Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Retained Earnings	Get a 7-Day Free Trial								-6.33	-8.39	-9.56	-11.17	-11.63

ASEP Medical Holdings Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

ASEP Medical Holdings (OTCPK:SEPSF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

JJ8:Germany ASEP:Canada

Address

730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7

Website

https://www.asepmedical.com

ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.